TY - JOUR
T1 - Menopausal age, adipokines, and heart failure incidence in postmenopausal women of Multi-Ethnic Study of Atherosclerosis
AU - Ebong, Imo A.
AU - Wilson, Machelle
AU - Michos, Erin D.
AU - Appiah, Duke
AU - Schreiner, Pamela J.
AU - Racette, Susan B.
AU - Allison, Matthew
AU - Watson, Karol
AU - Bertoni, Alain
N1 - Publisher Copyright:
© 2024 by The Menopause Society.
PY - 2024
Y1 - 2024
N2 - Objective: The mechanisms through which menopausal age influences heart failure (HF) development are controversial. Adiposity increases after menopause and could affect HF risk by influencing serum adipokine secretion. We investigated the associations of early menopause, and serum adipokines with incident HF in postmenopausal women. Methods: We included 746 postmenopausal women from the Multi-Ethnic Study of Atherosclerosis who reported their menopausal age and had data on adipokines and incident HF at the end of follow-up. Multivariable Cox proportional hazards models were used for analysis. Results: The mean age was 65.1 years. Over a median follow-up period of 17.8 years, 45 HF events occurred. After adjusting for waist circumference, other cardiovascular disease risk factors and myocardial infarction, the hazard ratios (95% confidence intervals) of incident HF attributable to early menopause were 4.50 (1.41-14.3), 4.64 (1.46-14.7), and 5.16 (1.59-16.7) in models that additionally included adiponectin, leptin, and resistin, respectively. In adjusted analyses, adiponectin was independently associated with incident HF 2.20 (1.35-3.57), while leptin and resistin were not. The interaction terms of early menopause with adiponectin, leptin, and resistin for incident HF were not significant (Pint = 0.08-0.82). Conclusions: Early menopause was significantly associated with incident HF. This association did not differ by serum adipokine levels. Only adiponectin was independently associated with incident HF in postmenopausal women when waist circumference, body mass index, and waist-hip ratio were used as the adiposity metric.
AB - Objective: The mechanisms through which menopausal age influences heart failure (HF) development are controversial. Adiposity increases after menopause and could affect HF risk by influencing serum adipokine secretion. We investigated the associations of early menopause, and serum adipokines with incident HF in postmenopausal women. Methods: We included 746 postmenopausal women from the Multi-Ethnic Study of Atherosclerosis who reported their menopausal age and had data on adipokines and incident HF at the end of follow-up. Multivariable Cox proportional hazards models were used for analysis. Results: The mean age was 65.1 years. Over a median follow-up period of 17.8 years, 45 HF events occurred. After adjusting for waist circumference, other cardiovascular disease risk factors and myocardial infarction, the hazard ratios (95% confidence intervals) of incident HF attributable to early menopause were 4.50 (1.41-14.3), 4.64 (1.46-14.7), and 5.16 (1.59-16.7) in models that additionally included adiponectin, leptin, and resistin, respectively. In adjusted analyses, adiponectin was independently associated with incident HF 2.20 (1.35-3.57), while leptin and resistin were not. The interaction terms of early menopause with adiponectin, leptin, and resistin for incident HF were not significant (Pint = 0.08-0.82). Conclusions: Early menopause was significantly associated with incident HF. This association did not differ by serum adipokine levels. Only adiponectin was independently associated with incident HF in postmenopausal women when waist circumference, body mass index, and waist-hip ratio were used as the adiposity metric.
KW - Adipokine
KW - Adiponectin
KW - Early menopause
KW - Heart failure
KW - Leptin
KW - Resistin
UR - http://www.scopus.com/inward/record.url?scp=85211117220&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85211117220&partnerID=8YFLogxK
U2 - 10.1097/GME.0000000000002456
DO - 10.1097/GME.0000000000002456
M3 - Article
C2 - 39626171
AN - SCOPUS:85211117220
SN - 1072-3714
JO - Menopause
JF - Menopause
M1 - 10.1097/GME.0000000000002456
ER -